These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited. Wang W; Prueksaritanont T Biopharm Drug Dispos; 2010 May; 31(4):253-63. PubMed ID: 20437464 [TBL] [Abstract][Full Text] [Related]
3. Interspecies allometric scaling. Part I: prediction of clearance in large animals. Mahmood I; Martinez M; Hunter RP J Vet Pharmacol Ther; 2006 Oct; 29(5):415-23. PubMed ID: 16958787 [TBL] [Abstract][Full Text] [Related]
4. Prediction of human plasma concentration-time profiles of monoclonal antibodies from monkey data by a species-invariant time method. Oitate M; Nakayama S; Ito T; Kurihara A; Okudaira N; Izumi T Drug Metab Pharmacokinet; 2012; 27(3):354-9. PubMed ID: 22146109 [TBL] [Abstract][Full Text] [Related]
5. Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable? Ducongé J; Fernández-Sánchez E; Alvarez D Biopharm Drug Dispos; 2004 May; 25(4):177-86. PubMed ID: 15108220 [TBL] [Abstract][Full Text] [Related]
6. Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data. Oitate M; Masubuchi N; Ito T; Yabe Y; Karibe T; Aoki T; Murayama N; Kurihara A; Okudaira N; Izumi T Drug Metab Pharmacokinet; 2011; 26(4):423-30. PubMed ID: 21606605 [TBL] [Abstract][Full Text] [Related]
7. Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations. Martinez M; Mahmood I; Hunter RP J Vet Pharmacol Ther; 2006 Oct; 29(5):425-32. PubMed ID: 16958788 [TBL] [Abstract][Full Text] [Related]
8. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532 [TBL] [Abstract][Full Text] [Related]
9. Interspecies scaling and comparisons in drug development and toxicokinetics. Ings RM Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215 [TBL] [Abstract][Full Text] [Related]
10. Comments on "a mathematical description of the functionality of correction factors used in allometry for predicting human drug clearance". Mahmood I Drug Metab Dispos; 2006 Mar; 34(3):507-9; author reply 510-1. PubMed ID: 16495384 [TBL] [Abstract][Full Text] [Related]
11. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. Ward KW; Smith BR Drug Metab Dispos; 2004 Jun; 32(6):603-11. PubMed ID: 15155551 [TBL] [Abstract][Full Text] [Related]
12. Interspecies scaling: role of protein binding in the prediction of clearance from animals to humans. Mahmood I J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1439-46. PubMed ID: 11185664 [TBL] [Abstract][Full Text] [Related]
13. A novel model for prediction of human drug clearance by allometric scaling. Tang H; Mayersohn M Drug Metab Dispos; 2005 Sep; 33(9):1297-303. PubMed ID: 15958605 [TBL] [Abstract][Full Text] [Related]
14. Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearance. Mahmood I; Green MD; Fisher JE J Clin Pharmacol; 2003 Jul; 43(7):692-7. PubMed ID: 12861964 [TBL] [Abstract][Full Text] [Related]
15. Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Tang H; Hussain A; Leal M; Mayersohn M; Fluhler E Drug Metab Dispos; 2007 Oct; 35(10):1886-93. PubMed ID: 17646280 [TBL] [Abstract][Full Text] [Related]
16. Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR. Morris ME; Yang X; Gandhi YA; Bhansali SG; Benincosa LJ Biopharm Drug Dispos; 2012 Jan; 33(1):1-14. PubMed ID: 22170504 [TBL] [Abstract][Full Text] [Related]
17. Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development. Offman E; Edginton AN Xenobiotica; 2013 Jun; 43(6):561-9. PubMed ID: 23244626 [TBL] [Abstract][Full Text] [Related]
18. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned? Deng R; Iyer S; Theil FP; Mortensen DL; Fielder PJ; Prabhu S MAbs; 2011; 3(1):61-6. PubMed ID: 20962582 [TBL] [Abstract][Full Text] [Related]
19. Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction. Dong JQ; Salinger DH; Endres CJ; Gibbs JP; Hsu CP; Stouch BJ; Hurh E; Gibbs MA Clin Pharmacokinet; 2011 Feb; 50(2):131-42. PubMed ID: 21241072 [TBL] [Abstract][Full Text] [Related]
20. Interspecies scaling of a camptothecin analogue: human predictions for intravenous topotecan using animal data. Ahlawat P; Srinivas NR Xenobiotica; 2008 Nov; 38(11):1377-85. PubMed ID: 18946781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]